Overview

A Pharmacokinetic (PK) Study of Three Types of E0302 Sustained Release (SR) Tablets Compared With E0302 Immediate Release (IR) Tablet Under Fed Conditions in Healthy Participants

Status:
Completed

Trial end date:
2019-06-26

Target enrollment:

Participant gender:

Summary

To assess the PK and safety after administration of three types of E0302 SR tablets (SR1, SR2, SR3) and E0302 IR tablet.

Phase:

Phase 1

Details

Lead Sponsor:

Eisai Co., Ltd.